Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px

News > All

Total search results: 9842 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 18 19 20 ... 97 98 99  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Boehringer Ingelheim. (12/12/17). "Press Release: Boehringer Ingelheim Initiates Real-world Study of Treatment Sequencing in EGFR Mutation-positive Lung Cancer". Ingelheim. 2017-12-12
CRISPR Therapeutics AG. (12/12/17). "Press Release: Vertex and CRISPR Therapeutics to Co-Develop and Co-Commercialize CTX001 as CRISPR/Cas9 Gene Edited Treatment for Sickle Cell Disease and ß-Thalassemia". Boston, MA, Cambridge, MA & Zug. 2017-12-12
Eyevensys S.A.S.. (12/12/17). "Press Release: Eyevensys Appoints Dr. Patricia Zilliox as Chief Executive Officer". Paris. 2017-12-12
Adrenomed AG. (12/11/17). "Press Release: Adrenomed AG Doses First Patient in Proof of Concept Study with Adrecizumab to Treat Patients with Early Septic Shock". Hennigsdorf. 2017-12-11
Hookipa Biotech AG. (12/11/17). "Press Release: Hookipa Biotech Raises $60 Million (€50 Million) in an Oversubscribed Round C Financing". Vienna. 2017-12-11
Idex Corporation. (12/11/17). "Press Release: Idex Corporation to Acquire thinXXS Microtechnology AG". Lake Forest, IL. 2017-12-11
Siemens AG. (12/11/17). "Press Release: Kingston Hospital NHS Foundation Trust Partners with Siemens Healthineers to Improve Efficiency by Transforming Radiology Department". Erlangen. 2017-12-11
VIB, Flanders Interuniversity Institute of Biotechnology. (12/11/17). "Press Release: New VIB Start-up Aelin Therapeutics Secures 27m € to Exploit Its Proprietary Pept-in Protein Knockdown Platform". 2017-12-11
Life Sciences Partners (LSP). (12/11/17). "Press Release: LSP Leads EUR 27 mln Series A Financing of New VIB Start-up Aelin Therapeutics to Exploit Its Proprietary Pept-in Protein Knockdown Platform". Leuven. 2017-12-11
Intellia Therapeutics, Inc.. (12/11/17). "Press Release: Intellia Therapeutics Announces New, Robust Genome Editing Data for Sickle Cell Disease at the American Society of Hematology Meeting". Atlanta, GA. 2017-12-11
Merck KGaA. (12/11/17). "Press Release: Merck Signs Distribution Agreement with Avanti Polar Lipids". Darmstadt. 2017-12-11
Boehringer Ingelheim. (12/11/17). "Press Release: Boehringer Ingelheim Marks Great Progress in Immuno-oncology Research Partnerships in 2017". Ridgefield, CT & Ingelheim. 2017-12-11
Evotec AG. (12/11/17). "Press Release: Evotec’s Academic Bridge Lab282 with Oxford University Celebrating One Year of impact". Hamburg. 2017-12-11
CRISPR Therapeutics AG. (12/10/17). "Press Release: CRISPR Therapeutics Announces Oral Presentation of New Data on CTX001, a CRISPR Gene-Edited Therapy for ß-Thalassemia and Sickle Cell Disease, at the ASH Annual Meeting". Zug & Cambridge, MA. 2017-12-10
bio.logis Genetic Information Management GmbH. (12/8/17). "Press Release: bio.logis GIM GmbH Concludes a Distribution Agreement with PGS.Holland BV". 2017-12-08
Qiagen N.V.. (12/8/17). "Press Release: Qiagen to Transfer U.S. Listing of Global Shares to NYSE". Germantown, MD & Hilden. 2017-12-08
CRISPR Therapeutics AG. (12/7/17). "Press Release: CRISPR Therapeutics Submits First Clinical Trial Application for a CRISPR Gene-Edited Therapy, CTX001 in ß-thalassemia". Zug & Cambridge, MA. 2017-12-07
Cell Medica Ltd.. (12/7/17). "Press Release: Cell Medica Announces Appointment of Industry Leader Dr Annalisa Jenkins as Chair". 2017-12-07
Coulter Partners. (12/7/17). "Press Release: Coulter Partners Helps Secure Industry Leader, Dr Annalisa Jenkins as Chair for Cell Medica". 2017-12-07
Novartis AG. (12/7/17). "Press Release: Novartis Tender Offer for Advanced Accelerator Applications Commences". Basel. 2017-12-07
Pieris Pharmaceuticals, Inc.. (12/7/17). "Press Release: Pieris Pharmaceuticals Announces Ethics and Regulatory Clearance to Begin Clinical Testing of Inhaled Respiratory Program, PRS-060/AZD1402". Boston, MA. 2017-12-07
Hepa Wash GmbH. (12/7/17). "Press Release: Hepa Wash Initiates Collaboration with German Accelerator Life Sciences to Prepare U.S. Expansion". Munich. 2017-12-07
ERS Genomics Ltd.. (12/6/17). "Press Release: ERS Genomics Licenses CRISPR/Cas9 Genome Editing Patents to Charles River". Dublin. 2017-12-06
BGI. (12/6/17). "Press Release: BGI and Hummingbird Diagnostics Sign Memorandum of Understanding". Shenzhen & Heidelberg. 2017-12-06
Leti. (12/6/17). "Press Release: Innovation in the Diagnosis of Breast Cancer". 2017-12-06
Paion AG. (12/6/17). "Press Release: Jürgen Beck, MD, Appointed as Chief Development Officer at Paion AG". Aachen. 2017-12-06
Proteros Biostructures GmbH. (12/6/17). "Press Release: Proteros Names Dave Lemus as New Executive Board Member". Munich. 2017-12-06
Probiodrug AG. (12/5/17). "Press Release: Probiodrug and Crossbeta Biosciences Extend Their Strategic Partnership in the Field of Alzheimer’s Disease Biomarkers". Halle (Saale) & Utrecht. 2017-12-05
Medigene AG. (12/5/17). "Press Release: Medigene Sells US-rights for Veregen and Raises Financial Guidance 2017". Martinsried. 2017-12-05
ERS Genomics Ltd.. (12/5/17). "Press Release: Horizon Extends Industry-Leading Gene Editing IP Portfolio through Expansion of CRISPR License Rights with ERS Genomics". Dublin & Cambridge. 2017-12-05
Fast Track Diagnostics S.à.r.l.. (12/5/17). "Press Release: Fast Track Diagnostics and UgenTec Announce New Interpretation Software for All FTD Real-time PCR Multiplex Kits". Luxembourg & Hasselt. 2017-12-05
Idorsia Ltd.. (12/4/17). "Press Release: Idorsia Announces Collaboration with Janssen Biotech on Aprocitentan (ACT-132577)". Allschwil. 2017-12-04
Sanofi S.A.. (12/4/17). "Press Release: Sanofi’s Toujeo Met Main Objective in Head-to-head Study versus Insulin Degludec". Paris. 2017-12-04
Ncardia. (12/4/17). "Press Release: Ncardia and Evotec Entered a Licencing Agreement for Disease Modelling Using iPS Cells". Gosselies. 2017-12-04
Sanofi S.A.. (12/1/17). "Press Release: Sanofi Ends Development of Clostridium Difficile Vaccine". Paris. 2017-12-01
Basilea Pharmaceutica Ltd.. (12/1/17). "Press Release: Basilea Extends Existing License Agreement with Pfizer for Antifungal Cresemba (isavuconazole) to China and Asia Pacific". Basel. 2017-12-01
Evotec AG. (12/1/17). "Press Release: Evotec Receives Clinical Milestone as Part of Its Discovery Alliance with Boehringer Ingelheim". Hamburg. 2017-12-01
Bayer AG. (12/1/17). "Press Release: CFIUS Completes Review of Proposed Merger of Bayer and Monsanto". Leverkusen & St. Louis, MI. 2017-12-01
Agena Bioscience, Inc.. (11/30/17). "Press Release: Agena Bioscience’s Liquid Biopsy Technology Awarded Horizon 2020 Grant by European Union". San Diego, CA. 2017-11-30
MorphoSys AG. (11/30/17). "Press Release: MorphoSys Signs Regional License Agreement for Antibody MOR202 with I-Mab". Planegg. 2017-11-30
Probiodrug AG. (11/30/17). "Press Release: Probiodrug Reports Third Quarter 2017 Business Update". Halle (Saale). 2017-11-30
Bayer AG. (11/30/17). "Press Release: Bayer Combines Pharmaceutical Research and Development Unit [Not intended for U.S. and UK Media]". Leverkusen. 2017-11-30
Bayer AG. (11/30/17). "Press Release: Phase III Trial of Radium-223 Dichloride in Combination with Abiraterone Acetate and Prednisone/Prednisolone for Patients with Metastatic Castration-resistant Prostate Cancer Unblinded Early [Not intended for U.S. an 2017-11-30
Carrick Therapeutics Ltd.. (11/30/17). "Press Release: Carrick Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of iIts Oral CDK7 inhibitor – CT7001". 2017-11-30
Akouos. (11/30/17). "Press Release: Akouos to Build Premier Gene Therapy Company Focused on Hearing and Balance Disorders with Backing from Leading Life Science Investors and Strategic Licenses from Massachusetts Eye and Ear and Lonza". Boston, MA & Hous 2017-11-30
Sanofi S.A.. (11/29/17). "Press Release: Sanofi Updates Information on Dengue Vaccine. New Analysis of Long-term Dengvaxia Data Found Differences in Vaccine Performance Based on Prior Dengue Infection". Paris. 2017-11-29
Epigenomics AG. (11/29/17). "Press Release: Supervisory Board of Epigenomics AG Appoints Albert Weber as Executive Vice President Finance and a Member of the Management Board (Vorstand)". Berlin & Germantown, MD. 2017-11-29
Bluebird Bio, Inc.. (11/29/17). "Press Release: Bluebird Bio Acquires Manufacturing Facility in North Carolina and Executes Multiple Global Supply Agreements to Enhance Ability to Deliver Gene Therapies to Patients". Cambridge, MA. 2017-11-29
Siemens AG. (11/29/17). "Press Release: Siemens Plans to List Siemens Healthineers on Frankfurt Stock Exchange". Munich. 2017-11-29
Cullinan Oncology, LLC. (11/29/17). "Press Release: Cullinan Oncology Adds Industry Leaders to Board, Bringing Significant Business & Healthcare Acumen". Cambridge, MA. 2017-11-29
Genedata AG. (11/28/17). "Press Release: New Release of Genedata Selector Revolutionizes Genomic Data Management and Analysis for Key Biopharma Applications". Basel. 2017-11-28
iOnctura S.A.. (11/28/17). "Press Release: iOnctura Announces Appointment of Leading International Scientific Advisory Board". Geneva. 2017-11-28
Charles River Laboratories International, Inc.. (11/28/17). "Press Release: Charles River Announces Success of Integrated Discovery Project with Enyo Pharma". Wilmington, MA & Lyon. 2017-11-28
Sphere Fluidics Ltd.. (11/27/17). "Press Release: Sphere Fluidics and Geneva Biotech Receive Eurostars Genome Editing Grant". Cambridge & Geneva. 2017-11-27
Medigene AG. (11/27/17). "Press Release: Patient Recruitment Completed for Phase I/II DC Vaccine Trial in AML". Planegg. 2017-11-27
BioMed X GmbH. (11/27/17). "Press Release: BioMed X and Boehringer Ingelheim Start New Joint Research Group in Bacterial Modulation of Innate Immunity". Heidelberg. 2017-11-27
Analytik Jena AG. (11/27/17). "Press Release: Analytik Jena and BAM Agree to Cooperate in Research". Jena. 2017-11-27
Bayer AG. (11/27/17). "Press Release: Bayer Is Expanding Its Collaboration with Bitkom". Leverkusen & Berlin. 2017-11-27
Biocartis Group N.V.. (11/27/17). "Press Release: Biocartis Launches CE-marked IVD RAS Liquid Biopsy Tests Developed under Partnership with Merck KGaA, Darmstadt, Germany". Mechelen. 2017-11-27
MorphoSys AG. (11/23/17). "Press Release: MorphoSys Announces that Its Licensee Janssen Has Received Approval for Tremfya (Guselkumab) in Europe for the Treatment of Moderate-to-Severe Plaque Psoriasis". Planegg. 2017-11-23
Royal Philips. (11/23/17). "Press Release: Philips-led Research Consortium Awarded EUR 6.3 Million EU Grant to Develop Integrated Approaches for Personalized Cancer Treatment". Amsterdam. 2017-11-23
Abivax S.A.. (11/20/17). "Press Release: Abivax Enrolls First Ulcerative Colitis Patient in New ABX464 Proof-of-Concept Clinical Trial". Paris. 2017-11-20
Boehringer Ingelheim. (11/20/17). "Press Release: Boehringer Ingelheim Makes Many of Its Best Molecules Openly Available to the Scientific Community via opnMe.com to Unlock Their Full Potential". Ingelheim. 2017-11-20
Jennewein Biotechnologie GmbH. (11/20/17). "Press Release: EU Approval for 2'-fucosyllactose". 2017-11-20
Arsanis, Inc.. (11/20/17). "Press Release: Arsanis Announces Closing of Initial Public Offering". Waltham, MA & Vienna. 2017-11-20
Roche. (11/17/17). "Press Release: FDA Approves Roche’s Gazyva for Previously Untreated Advanced Follicular Lymphoma". Basel. 2017-11-17
Roche. (11/17/17). "Press Release: Roche to Acquire Viewics, Inc. to Provide Data-driven Lab Business Analytics and Add further Digital Capabilities along the Laboratory Value Chain". Basel. 2017-11-17
Ncardia. (11/17/17). "Press Release: Ncardia Announces Completion of €10.5m Investment Round". Gosselies. 2017-11-17
Formycon AG. (11/16/17). "Press Release: Formycon Sets Course for the Future and Confirms Management Board Members until mid-2022". Munich. 2017-11-16
Goodwin Procter LLC. (11/16/17). "Press Release: Intellia Therapeutics Closes $150 Million Public Offering of Common Stock". 2017-11-16
High-Tech Gründerfonds Management GmbH. (11/16/17). "Press Release: EWE Invests in High-Tech Gründerfonds III". 2017-11-16
Molecular Health GmbH. (11/16/17). "Press Release: Molecular Health and U.S. Food and Drug Administration (FDA) Extend Software Collaboration to Drug Safety Prediction". Cambridge, MA. 2017-11-16
Ablynx N.V.. (11/16/17). "Press Release: Ablynx Announces Results for the First Nine Months of 2017 and a Year-to-Date Business Update". Ghent. 2017-11-16
Biocartis Group N.V.. (11/16/17). "Press Release: Biocartis Q3 2017 Business Update". Mechelen. 2017-11-16
bio.logis Genetic Information Management GmbH. (11/16/17). "Press Release: Laboratory Group Laboratoires Réunis Capitalizes Genetic Information Management Software Suite for Complex Laboratory Reports". 2017-11-16
Curetis N.V.. (11/16/17). "Press Release: Curetis Publishes Business and Financial Update for the First Nine Months of 2017". Amsterdam & Holzgerlingen. 2017-11-16
Roche. (11/16/17). "Press Release: FDA Approves Roche’s Hemlibra (emicizumab-kxwh) for Haemophilia A with Inhibitors". Basel. 2017-11-16
Boehringer Ingelheim. (11/15/17). "Press Release: Key Sub-analyses of RE-DUAL PCI Showed Large Reductions in the Incidence of Bleeding Complications if Pradaxa (dabigatran etexilate) Dual Therapy Was Used Instead of Warfarin Triple Therapy". Ingelheim. 2017-11-15
Arvinas, LLC. (11/15/17). "Press Release: Arvinas Expands Strategic License Agreement with Genentech". New Haven, CT. 2017-11-15
Xeltis AG. (11/15/17). "Press Release: Xeltis Closes €45 Million in Oversubscribed Series C Financing to Advance Aortic and Pulmonary Valve Programs". Zurich & Eindhoven. 2017-11-15
Arsanis, Inc.. (11/15/17). "Press Release: Arsanis Announces Pricing of Initial Public Offering". Waltham, MA & Vienna. 2017-11-15
High-Tech Gründerfonds Management GmbH. (11/14/17). "Press Release: Scipio Bioscience Announces Its Seed Funding". 2017-11-14
Boehringer Ingelheim. (11/14/17). "Press Release: Jardiance Reduced Risk of Cardiovascular Death in Adults with Type 2 Diabetes and Peripheral Artery Disease". Ingelheim & Indianapolis, IN. 2017-11-14
Boehringer Ingelheim. (11/14/17). "Press Release: New RE-VERSE AD Analyses Provide Additional Insights on Impact of Praxbind (idarucizumab) in Pradaxa (dabigatran etexilate) Patients with Gastrointestinal Bleeding or Needing Emergency Surgery". Ingelheim 2017-11-14
Loxo Oncology, Inc.. (11/14/17). "Press Release: Loxo Oncology Announces Global Development and Commercialization Partnership with Bayer for Larotrectinib and LOXO-195". Stamford, CT. 2017-11-14
Qiagen N.V.. (11/14/17). "Press Release: Qiagen’s GeneReader NGS System Delivers Accuracy and Ease of Use for Clinical Research in Oncology". Hilden & Germantown, MD. 2017-11-14
Definiens AG. (11/13/17). "Press Release: Definiens Strengthens Position as Global Service Provider in Biopharma. Jacques Corriveau Joining as General Manager North America". Munich. 2017-11-13
CRISPR Therapeutics AG. (11/13/17). "Press Release: CRISPR Therapeutics and Casebia Collaborate with CureVac on mRNA for Gene-Editing Programs". Zug, Cambridge, MA, Tübingen & Boston, MA. 2017-11-13
Boehringer Ingelheim. (11/13/17). "Press Release: Cyltezo, Adalimumab Biosimilar from Boehringer Ingelheim, Approved in Europe for the Treatment of Multiple Chronic Inflammatory Diseases". Ingelheim. 2017-11-13
CRISPR Therapeutics AG. (11/13/17). "Press Release: CRISPR Therapeutics Announces Appointment of Michael Tomsicek as Chief Financial Officer". Zug & Cambridge, MA. 2017-11-13
Merck KGaA. (11/13/17). "Press Release: Merck and International Diabetes Federation Partner to Help Address Global Type 2 Diabetes Epidemic [The information contained in this release is not appropriate for audiences in the USA and Canada]". Darmstadt. 2017-11-13
Merck KGaA. (11/13/17). "Press Release: Merck Introduces Stericup Quick Release System for Improved Cell Culture Filtration". Darmstadt. 2017-11-13
Merck KGaA. (11/13/17). "Press Release: Merck Receives FDA Approval for New Gonal-f Prefilled Pen [Not intended for U.S. and UK based media]". Darmstadt. 2017-11-13
Royal Philips. (11/13/17). "Press Release: German Armed Forces to Use Customized Philips Lumify Ultrasound for Its Emergency and Rescue Operations". Amsterdam. 2017-11-13
Qiagen N.V.. (11/13/17). "Press Release: Qiagen Celebrates Surpassing 2,000 Cumulative Placements of QIAsymphony". Hilden & Germantown, MD. 2017-11-13
EBD Group. (11/13/17). "Press Release: BIO-Europe 2017 Brings over 4,000 Biotech and Pharma Execs to Berlin and Breaks All Previous Partnering Records". Carlsbad, CA & Berlin. 2017-11-13
GNA Biosolutions GmbH. (11/13/17). "Press Release: GNA Biosolutions Reveals New Ultrafast PCR Platform at Medica". Düsseldorf. 2017-11-13
Affimed N.V.. (12/11/17). "Press Release: Affimed Presents Data from Phase 1b Combination Study of AFM13 with Pembrolizumab at ASH". Heidelberg. 2017-11-12
Boehringer Ingelheim. (11/10/17). "Press Release: Boehringer Ingelheim Presents New Data for Pradaxa and Its Specific Reversal Agent Praxbind at AHA Scientific Sessions 2017". Ingelheim. 2017-11-10
DiaSorin S.p.A.. (11/9/17). "Press Release: Growth in Revenues and Net Profit in Q3 2017". Saluggia. 2017-11-09
next pagenext page 1 2 3 ... 18 19 20 ... 97 98 99  next pagenext page



Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Kentro Design Corporate and Web Design Berlin 650x65px

» top